Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
D000328:Adult; D003622:Dapsone / Q000008:administration & dosage* / Q000627:therapeutic use; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000627:therapeutic use; D007539:Isonicotinic Acids / Q000008:administration & dosage*; D007917:Leprostatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D011446:Prospective Studies; D011515:Prothionamide / Q000008:administration & dosage* / Q000627:therapeutic use; D011897:Random Allocation; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use
D004338:Drug Combinations; D007539:Isonicotinic Acids; D007917:Leprostatic Agents; C011004:isoprodian; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid; D012293:Rifampin